Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies
SIR Alpajaro, JAK Harris, CP Evans - Prostate Cancer and Prostatic …, 2019 - nature.com
Background Non-metastatic castration resistant prostate cancer (M0CRPC) is a
heterogenous disease state affecting an estimated 100,000 men in the United States …
heterogenous disease state affecting an estimated 100,000 men in the United States …
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies.
SIR Alpajaro, JAK Harris, CP Evans - Prostate Cancer and Prostatic …, 2018 - europepmc.org
BACKGROUND: Non-metastatic castration resistant prostate cancer (M0CRPC) is a
heterogenous disease state affecting an estimated 100,000 men in the United States …
heterogenous disease state affecting an estimated 100,000 men in the United States …
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies
SIR Alpajaro, JAK Harris, CP Evans - Prostate Cancer and Prostatic …, 2019 - hero.epa.gov
Background Non-metastatic castration resistant prostate cancer (M0CRPC) is a
heterogenous disease state affecting an estimated 100,000 men in the United States …
heterogenous disease state affecting an estimated 100,000 men in the United States …
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies
SIR Alpajaro, JAK Harris… - Prostate cancer and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Non-metastatic castration resistant prostate cancer (M0CRPC) is a
heterogenous disease state affecting an estimated 100,000 men in the United States …
heterogenous disease state affecting an estimated 100,000 men in the United States …